The efficacy was evaluated by HAMD scales.
采用汉密尔顿抑郁量表(HAMD)进行疗效评定。
The therapeutic effect was evaluated by HAMD periodically.
采用汉密尔顿抑郁量表(HAMD)定期进行疗效评定。
Hamilton depression rating scale (HAMD) was used to evaluate the severity of depression.
采用汉密尔顿抑郁量表(HAMD)评定抑郁的严重程度。
Method:198 patients with stroke were evaluated by Hamilton depression rating scale (HAMD).
方法：采用汉密尔顿抑郁量表（HAMD）对198例脑卒中患者进行现状调查。
There was a certain direct correlation between HAMD reductive ratio and life quality (P<0.01~0.05).
HAMD减分率与生活质量呈一定正相关性（P＜0.01～0.05）。
Methods Measures of EPQ, SAS and HAMD were conducted in 86 patents with insomnia and compared with norms.
方法对86例失眠症患者治疗前进行epq、SAS、HAMD测定并与常摸对比分析。
Objective To explore the validity and reliability of the 6-item Hamilton Depression Rating Scale (HAMD-6).
目的检验汉密顿抑郁量表6项版本（HAMD-6）的信度与效度。
Results: The results of ITAQ were consistent with clinical standard, while significantly different with HAMD.
结果：ITAQ与临床标准评定结果一致，与HAMD评定结果差异显著。
Assessed by the HAMD depression scale, respectively, before treatment and after treatment 1, 2, 3, 4 weeks assessed.
经hamd量表评定抑郁状态，分别于治疗前及治疗后第1、2、3、4周进行评定。
Results treatment group and control group after treatment of post-stroke depression HAMD, NDS, ADL were significantly different.
结果治疗组和对照组治疗后脑卒中后抑郁的HAMD、NDS、ADL均有显著差异。
HAMD scores were compared before and after treatment were significantly different, between the two groups showed no significant difference.
治疗前后HAMD评分比较两组均有显著性差异，两组间则无显著性差异。
Changes of scores for Hamilton Depression Rating Scale (HAMD) and Pittsburgh Sleep Quality Index (PSQI) were investigated in the two groups.
观察两组汉密尔顿(HAMD)量表及匹兹堡睡眠质量指数(PSQI)量表治疗前后的变化情况。
HAMD and TESS were used to assess the efficacy and side effects before the treatment and 1st week, 2nd week, 4th week and 6th week after it.
疗程6周，采用汉密尔顿抑郁量表(HAMD)和副反应量表(tess)法，在治疗前，治疗后第1,2,4,6周，分别评定药物疗效和不良反应。
The patients had been regularly tested by the Hamilton Depression Rating Scale for Depression(HAMD), the lesion location was analyzed by MRI.
所有患者均常规行汉密尔顿抑郁量表（HAMD）评分，根据头颅MRI结果分析病变部位。
Hamilton depression rating scale (HAMD), clinical general impressional scale (CGI) and treatment emergent symptom scale (TESS) were assessed.
采用汉密尔顿抑郁量表(HAMD)、临床疗效总评量表(CGI)、副反应量表(TESS)评定疗效及不良反应。
All patients were evaluated by Hamilton Depression scale (HAMD) and Functional Comprehensive Assessment scale (FCA) before and after the treatment.
治疗前后评定用汉密尔顿抑郁量表(HAMD)和功能综合评定量表(FCA)。
Significant differences were also found in the factor analysis of HAMD scores, illness behaviour, course of illness, age of onset and family history.
两组在HAMD因子分析、疾病行为与态度、病程演变及发病背景方面存在显著差异。
Method HAMD depression measuring scale tests were performed for the clinical symptom characteristics in patients with depressive neurosis according to CCMD - 2 - r.
方法对符合CCMD-2 - R的抑郁性神经症患者进行HAMD抑郁量表检测，找出临床症状特征。
Results: The score of Y-BOCS, HAMD, HAMA in obsessive-compulsive disorder group was higher than that in schizophrenia group with obsessive-compulsive symptoms(P<0.01).
结果：强迫症组的Y-BOCS、HAMD、HAMA等总分明显高于伴强迫症状的精神分裂症组（P<0.01）； 治疗后各量表总分明显下降（P<0.01）。
Method The Coping Styles Questionnaire and Hamilton Depression Scale (HAMD) were used in 78 patients with depression pretreatment and post treatment and 86 healthy control.
方法采用应付方式问卷，评定78例抑郁症患者治疗前、后应付方式的改变，并与86例正常对照比较，用HAMD评定疾病的严重程度和疗效。
Methods the patients were randomly assigned into venlafaxine and maprotiline group and tested with HAMD, HAMA and TESS at the time of weeks 1, 2, 4, 6 weeks after treatment.
方法采用随机对照方法，以马普替林为对照组，应用HAMD、HAMA、TESS量表，在疗前、疗后1、2、4、6周进行疗效及副反应评定。
The state of depression was measured with Hamilton rating scale for depression (HAMD) and serum BDNF levels in depression patients and healthy controls were assayed by ELISA.
采用汉密尔顿抑郁量表(HAMD)评定患者组及对照组的抑郁状态；采用ELISA检测各组血清bdnf水平。
Results Study group at the 4th weekend, CGI and HAMD scores were significantly lower than the same period in the control group, two groups had significant difference(P<0.05).
结果研究组在第4周末CG I及HAMD评分均显著低于同期对照组，两组比较差异有统计学意义（P〈0.05）。
Objective to discuss the different factorial structure of HAMD Scale between the patients of liver Qi stagnation syndrome and liver stagnation and spleen deficiency syndrome.
目的探讨中医辨证为肝郁气滞型与肝郁脾虚型抑郁症患者在HAMD抑郁量表结构因素方面的差异。
Objective To investigate an improvement in HAMD sleep score and its relationship with treatment frequency in treatment of dyssomnia by needle embedding plus SSRIs in depression patients.
目的观察埋针配合SSRI类药物治疗抑郁症睡眠障碍对HAMD量表睡眠积分改善的差异以及与治疗频次的关系。
Methods The clinical symptoms and therapeutic effects were assessed with HAMD scales, and then evaluate the correlation of activities of daily living and depression complicated by stroke.
方法采用汉密尔顿抑郁量表进行抑郁症状评定和临床疗效比较分析，进一步分析日常生活依赖程度及并发抑郁的相关性。
Methods 30 depression patients were treated with citalopram and other 30 patients with armitpriptyline. The effect and side effects were assessed with HAMD and TESS, and the cost was contrasted.
方法采用HA MD和TESS，对30例服用西酞普兰和30例服用阿米替林的抑郁症患者的疗效和副反应进行比较，并对其费用进行比较分析。
Methods 30 depression patients were treated with citalopram and other 30 patients with armitpriptyline. The effect and side effects were assessed with HAMD and TESS, and the cost was contrasted.
方法采用HA MD和TESS，对30例服用西酞普兰和30例服用阿米替林的抑郁症患者的疗效和副反应进行比较，并对其费用进行比较分析。
应用推荐